Biotech Lab 4.0
Vaccine development by design

A revolutionary way to accelerate, control and implement processes in real time by creating intelligent networks of equipment and open data systems that govern each other.
AchilleS Vaccines Biotech Lab 4.0 is a new model of early stage development for new biopharmaceutical products, particularly those containing, or consisting of, recombinant proteins (e.g. vaccines, immuno-therapeutics, ), and a new model of pre-clinical R&D.
Our Technology
AchilleS Vaccines exploits integrated technological platforms to identify, select and develop future approaches to deliver effective products.
They Talk About Us
Latest News
-
Momentum for monoclonal antibodies in the fight against Covid-19
In Europe, the fight against the Covid-19 pandemic was mainly focused on developing a vast number of vaccines through the use of different technologies. But
-
Dalla Polio al Covi-19: Siena in prima linea contro le epidemie
Sabato 24 ottobre 2020, nella giornata mondiale della Polio, grazie al Rotary Club Montaperti con il patrocinio del Comune di Siena, si è tenuto un
-
The Race to detect tomorrow’s diseases today
Thousands of viruses have the potential to leap from animals to humans Pietro Mastroeni, Chief Scientific Advisor at Achilles Vaccines and Research Leader at University of